Extracellular vesicles could be personalised drug delivery vehicles
Researchers developed an approach and platform to create large amounts of fillable and targeted nanovesicles to deliver drugs to tumours in mice...
List view / Grid view
Researchers developed an approach and platform to create large amounts of fillable and targeted nanovesicles to deliver drugs to tumours in mice...
An international research consortium has identified a novel gene involved in breast cancer
A discovery sheds light on how cancerous cells differ from healthy ones and could lead to the development of new strategies for therapeutic intervention for difficult-to-treat cancers...
Research shows that preventing or reversing ‘T-cell exhaustion’ with targeted therapies could enhance the effects of immunotherapy.
Researchers have reported a potential new role for some bacteria on the skin, protecting against cancer...
Researchers have developed the first-ever high-throughput, genome-scale imaging-based approach to investigate protein stability...
Researchers have discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer...
A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer...
An international team of scientists has developed a water-soluble “warped nanographene”, a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.
Researchers have shown that by preventing loss of membrane asymmetry it's possible to control the immune response...
Researchers have uncovered the architecture of the spindle pole body in yeast...
A study in mice has suggested that iPS cells may train the immune system to attack or even prevent tumours...
Researchers in Spain provide specific examples of metabolomics applications in the field of clinical pharmacology and precision medicine, focusing on the therapeutic management of cancer.
Scientists have designed a new machine learning algorithm that uses time-series data to uncover underlying biological networks.
A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumour growth.